bf/NASDAQ:TVTX_icon.jpeg

COM:TRAVERE

Travere Therapeutics

  • Stock

Last Close

17.86

21/11 21:00

Market Cap

725.51M

Beta: -

Volume Today

895.16K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
400.25K
-
1.67M
316.80%
2.68M
60.71%
4.09M
52.50%
5.49M
34.16%
5.85M
6.66%
6.84M
17.00%
7.46M
8.99%
7.12M
4.60%
8.17M
14.73%
average payables
2.29M
-
5.34M
133.30%
7.38M
38.26%
7.58M
2.69%
13.23M
74.53%
12.95M
2.15%
16.78M
29.65%
19.37M
15.43%
13.64M
29.60%
16.22M
18.91%
29.48M
81.80%
average receivables
3.98M
-
33.63M
745.12%
62.33M
85.33%
39.62M
36.45%
14.18M
64.20%
16.27M
14.72%
25.56M
57.09%
24.61M
3.69%
16.40M
33.36%
18.91M
15.30%
book value per share
-1.29
-
-1.49
15.32%
8.94
701.25%
8.32
6.93%
7.56
9.11%
7.87
4.10%
5.22
33.63%
4.44
14.96%
5.05
13.65%
0.67
86.69%
2.70
302.31%
capex per share
-0.39
-
-0.16
59.50%
-0.21
32.41%
-0.32
53.86%
-0.36
12.12%
-0.49
34.85%
-0.37
24.55%
-2.52
585.75%
-0.40
83.99%
-0.45
10.96%
-0.57
27.04%
capex to depreciation
-25.69
-
-0.73
97.14%
-0.52
28.48%
-0.74
40.78%
-0.79
6.47%
-1.06
34.12%
-0.76
27.73%
-4.88
539.30%
-0.91
81.39%
-0.86
4.86%
-0.94
8.94%
capex to operating cash flow
0.32
-
0.09
72.60%
12.69
14,576.91%
7.47
41.12%
-1.89
125.33%
0.79
141.71%
0.27
66.13%
2.80
948.66%
1.63
41.77%
0.15
90.61%
0.15
1.55%
capex to revenue
-0.14
-
-0.07
49.93%
-0.09
26.83%
-0.09
1.30%
-0.12
32.66%
-0.09
25.99%
-0.60
580.74%
-0.11
82.43%
-0.13
26.87%
-0.29
116.02%
cash per share
0.43
-
1.11
156.72%
6.84
517.54%
6.92
1.09%
7.75
12.12%
11.66
50.40%
9.41
19.29%
7.61
19.19%
9.24
21.49%
7.06
23.58%
7.63
8.08%
days of inventory on hand
511.73
-
423.63
17.21%
226.50
46.53%
541.78
139.19%
371.08
31.51%
424.14
14.30%
453.30
6.88%
393.46
13.20%
332.79
15.42%
60.92
81.69%
days payables outstanding
4.55K
-
1.28K
71.98%
602.88
52.76%
1.92K
218.04%
459.24
76.05%
1.86K
304.14%
722.91
61.05%
814.79
12.71%
831.25
2.02%
269.79
67.54%
days sales outstanding
103.01
-
216.70
110.37%
178.58
17.60%
32.68
81.70%
32.20
1.47%
37.57
16.68%
60.86
61.98%
25.93
57.39%
28.66
10.52%
53.23
85.73%
debt to assets
0.62
-
0.09
86.14%
0.08
1.30%
0.09
2.44%
0.31
254.12%
0.34
10.42%
0.35
4.66%
0.34
4.84%
0.61
79.60%
0.48
20.04%
debt to equity
-2.25
-
0.15
106.51%
0.14
1.38%
0.15
6.54%
0.68
344.52%
0.93
35.49%
1.02
10.08%
0.87
14.94%
9.51
996.59%
1.90
79.99%
dividend yield
0.31
-
earnings yield
-0.34
-
-0.36
6.34%
0.18
150.07%
-0.07
137.77%
-0.07
6.91%
-0.11
53.47%
-0.24
117.03%
-0.13
46.31%
-0.10
25.84%
-0.21
114.18%
-0.17
19.67%
enterprise value
93.44M
-
372.27M
298.41%
653.47M
75.54%
703.79M
7.70%
762.56M
8.35%
1.03B
35.03%
743.65M
27.78%
1.43B
91.79%
1.95B
36.96%
1.69B
13.66%
1.01B
39.86%
enterprise value over ebitda
-6.66
-
-7.03
5.50%
-19.71
180.45%
-101.00
412.47%
-25.69
74.57%
-16.17
37.04%
-10.68
33.99%
-20.68
93.76%
-14.23
31.21%
-6.90
51.48%
-3.06
55.72%
ev to operating cash flow
-5.31
-
-8.12
52.84%
-1.18K
14,427.61%
-440.97
62.62%
103.01
123.36%
-41.26
140.05%
-12.77
69.04%
-33.37
161.21%
-132.06
295.76%
-9.05
93.14%
-3.62
59.99%
ev to sales
13.20
-
6.54
50.44%
5.27
19.47%
4.92
6.58%
6.27
27.38%
4.24
32.35%
7.19
69.56%
8.59
19.40%
7.96
7.36%
6.98
12.21%
free cash flow per share
-1.63
-
-1.99
22.05%
-0.23
88.63%
-0.37
61.71%
-0.17
53.37%
-1.10
548.23%
-1.74
57.77%
-3.42
96.27%
-0.65
80.97%
-3.37
417.73%
-4.34
28.78%
free cash flow yield
-0.23
-
-0.16
30.20%
-0.01
92.79%
-0.02
64.78%
-0.01
58.11%
-0.05
503.54%
-0.12
151.42%
-0.13
2.26%
-0.02
83.29%
-0.16
664.16%
-0.48
201.25%
graham net net
-2.30
-
-5.53
140.41%
1.87
133.90%
2.40
28.00%
2.23
7.03%
2.33
4.55%
0.74
68.11%
-0.13
117.06%
1.57
1,339.86%
-2.57
263.03%
-0.01
99.65%
graham number
8.31
-
12.17
46.43%
26.51
117.81%
15.57
41.27%
16.19
4.00%
21.21
30.99%
20.16
4.93%
18.88
6.38%
18.49
2.03%
8.13
56.05%
9.55
17.54%
income quality
0.52
-
0.41
20.52%
-0.00
101.14%
0.03
805.06%
-0.12
472.00%
0.24
296.12%
0.40
63.56%
0.25
36.54%
0.08
67.44%
0.67
714.44%
0.74
11.23%
intangibles to total assets
0.61
-
0.70
14.45%
0.32
54.88%
0.35
9.86%
0.36
2.48%
0.26
25.88%
0.26
1.17%
0.25
2.96%
0.19
24.67%
0.22
12.83%
0.13
38.58%
interest coverage
-1.23
-
-1.45
18.01%
-6.55
351.58%
-1.69
74.22%
-45.28
2,581.76%
-8.16
81.98%
-5.30
35.03%
-3.96
25.36%
-6.93
75.05%
-22.31
222.12%
-33.24
48.98%
interest debt per share
1.37
-
5.54
303.41%
1.54
72.22%
2.13
38.57%
1.19
44.04%
5.62
371.21%
5.28
6.04%
4.93
6.68%
4.72
4.36%
6.57
39.29%
5.30
19.33%
inventory turnover
0.71
-
0.86
20.79%
1.61
87.03%
0.67
58.19%
0.98
46.00%
0.86
12.51%
0.81
6.43%
0.93
15.21%
1.10
18.23%
5.99
446.29%
invested capital
-2.25
-
0.15
106.51%
0.14
1.38%
0.15
6.54%
0.68
344.52%
0.93
35.49%
1.02
10.08%
0.87
14.94%
9.51
996.59%
1.90
79.99%
market cap
99.44M
-
306.70M
208.44%
647.38M
111.08%
700.37M
8.19%
816.88M
16.64%
915.00M
12.01%
601.23M
34.29%
1.30B
115.51%
1.86B
43.34%
1.34B
27.80%
667.66M
50.21%
net current asset value
-31.31M
-
-135.39M
332.42%
89.50M
166.11%
114.84M
28.31%
98.59M
14.14%
104.77M
6.26%
45.46M
56.61%
14.18M
68.81%
108.31M
663.74%
-143.30M
232.31%
28.67M
120.01%
net debt to ebitda
0.43
-
-1.24
389.50%
-0.18
85.14%
-0.49
166.91%
1.83
472.78%
-1.80
198.44%
-2.04
13.51%
-1.89
7.39%
-0.70
62.98%
-1.42
101.92%
-1.04
26.20%
net income per share
-2.38
-
-4.43
85.94%
3.49
178.90%
-1.29
137.06%
-1.54
18.99%
-2.54
64.83%
-3.46
36.19%
-3.56
3.05%
-3.01
15.55%
-4.37
45.11%
-1.50
65.66%
operating cash flow per share
-1.24
-
-1.83
47.78%
-0.02
99.10%
-0.04
161.32%
0.19
542.65%
-0.62
423.26%
-1.37
122.74%
-0.90
34.61%
-0.25
72.50%
-2.92
1,081.85%
-3.77
29.04%
payables turnover
0.08
-
0.29
256.89%
0.61
111.66%
0.19
68.56%
0.79
317.53%
0.20
75.26%
0.50
156.74%
0.45
11.28%
0.44
1.98%
1.35
208.11%
receivables turnover
3.54
-
1.68
52.47%
2.04
21.35%
11.17
446.44%
11.34
1.49%
9.72
14.29%
6.00
38.27%
14.08
134.70%
12.74
9.52%
6.86
46.16%
research and ddevelopement to revenue
1.69
-
0.50
70.21%
0.53
5.06%
0.50
4.88%
0.75
49.35%
0.80
6.70%
0.66
17.35%
0.92
39.15%
1.11
20.28%
1.64
47.19%
return on tangible assets
-4.27
-
-2.75
35.55%
0.34
112.16%
-0.14
141.77%
-0.18
27.56%
-0.20
10.28%
-0.33
66.51%
-0.37
14.01%
-0.29
23.30%
-0.53
84.14%
-0.16
69.17%
revenue per share
1.13
-
2.98
164.45%
3.61
21.31%
4.00
10.68%
4.06
1.65%
4.14
1.95%
4.17
0.74%
3.80
8.86%
3.33
12.54%
1.96
41.19%
roe
1.85
-
2.98
61.24%
0.39
86.88%
-0.16
139.82%
-0.20
30.92%
-0.32
58.33%
-0.66
105.18%
-0.80
21.18%
-0.60
25.69%
-6.50
990.21%
-0.55
91.46%
roic
1.31
-
-1.68
227.91%
-0.16
90.23%
-0.14
16.18%
-0.16
18.37%
-0.15
7.50%
-0.23
55.56%
-0.16
32.29%
-0.23
47.06%
-0.52
123.89%
-0.62
19.20%
sales general and administrative to revenue
2.11
-
0.80
62.35%
0.73
7.86%
0.67
8.55%
0.63
5.94%
0.74
16.54%
0.68
6.89%
0.66
3.78%
1.04
57.64%
1.83
76.03%
shareholders equity per share
-1.29
-
-1.49
15.32%
8.94
701.25%
8.32
6.93%
7.56
9.11%
7.87
4.10%
5.22
33.63%
4.44
14.96%
5.05
13.65%
0.67
86.69%
2.70
302.31%
stock based compensation to revenue
0.56
-
0.26
54.01%
0.22
15.98%
0.17
20.38%
0.12
30.59%
0.12
0.02%
0.12
1.08%
0.14
13.58%
0.18
36.63%
0.30
64.87%
tangible asset value
-30.90M
-
-132.45M
328.67%
137.50M
203.81%
124.79M
9.24%
107.38M
13.95%
130.63M
21.65%
63.06M
51.72%
57.09M
9.47%
153.68M
169.19%
-102.19M
166.49%
96.32M
194.26%
tangible book value per share
-2.18
-
-5.29
143.02%
4.10
177.51%
3.37
17.68%
2.77
17.88%
3.23
16.64%
1.49
53.90%
1.20
19.37%
2.55
112.58%
-1.62
163.34%
1.30
180.21%
working capital
-27.71M
-
-70.20M
153.37%
216.13M
407.86%
249.09M
15.25%
240.14M
3.59%
391.06M
62.85%
333.62M
14.69%
317.75M
4.76%
458.74M
44.37%
344.27M
24.95%
438.87M
27.48%

All numbers in (except ratios and percentages)